Parallel Advisors’s Pactiv Evergreen Inc. Common stock PTVE Stock Holding History

Parallel Advisors’s Portfolio PTVE Stock Details PTVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-884	Closed	-$15.9K	–	3739
2025 Q1	$15.9K	Buy	884 +20	+2%	+$356	﹤0.01%	2249
2024 Q4	$15.1K	Hold	864	–	–	﹤0.01%	2259
2024 Q3	$9.95K	Hold	864	–	–	﹤0.01%	2399
2024 Q2	$9.78K	Hold	864	–	–	﹤0.01%	2326
2024 Q1	$12.4K	Hold	864	–	–	﹤0.01%	2214
2023 Q4	$11.8K	Buy	864 +781	+941%	+$8.22K	﹤0.01%	2217
2023 Q3	$675	Sell	83 -449	-84%	-$3.67K	﹤0.01%	3051
2023 Q2	$4.03K	Buy	532 +270	+103%	+$2.06K	﹤0.01%	2509
2023 Q1	$2.1K	Buy	+262	New	+$2.69K	﹤0.01%	2760
2022 Q1	–	Sell	-9	Closed	–	–	3323
2021 Q4	$0	Buy	+9	New	+$117	﹤0.01%	3329

Parallel Advisors's PTVE Position: Q2 2025 in Review

Parallel Advisors sold out of Pactiv Evergreen Inc. Common stock (PTVE) in Q2 2025, closing a stake of 884 shares — an estimated $15.9K sold.

Parallel Advisors first reported a position in PTVE in Q4 2021 and held it in 10 quarters. The position peaked at $15.9K in Q1 2025. 0 funds tracked by Wall St. Rank hold PTVE as of Q2 2025.

Parallel Advisors reported no remaining Pactiv Evergreen Inc. Common stock position as of Q2 2025 after selling out during the quarter.
Parallel Advisors sold 884 Pactiv Evergreen Inc. Common stock shares in Q2 2025, an estimated $15.9K.
Parallel Advisors first reported a position in Pactiv Evergreen Inc. Common stock in Q4 2021 and held it in 10 quarters.
Parallel Advisors's Pactiv Evergreen Inc. Common stock position peaked at $15.9K in Q1 2025.
0 funds tracked by Wall St. Rank held Pactiv Evergreen Inc. Common stock as of Q2 2025.

Based on Parallel Advisors's 13F filing for Q2 2025, filed 8 Jul 2025.